- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Witte, T.J.M. de"
Now showing items 51-100 of 356
-
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT Basak, G.W.; Wiktor-Jedrzejczak, W.; ; Schoemans, H.; Ljungman, P.; Kobbe, G.; Beguin, Y.; Lang, P.; Koenecke, C.; Sykora, K.W.; et al.2015, Article / Letter to editor (American Journal of Transplantation, vol. 15, iss. 3, (2015), pp. 705-714)
sine al.
-
-
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT Chalandon, Y.; Passweg, J.R.; ; Iacobelli, S.; Apperley, J.; ; ; Robin, M.; Fedele, R.; Bron, D.; et al.2014, Article / Letter to editor (Haematologica, vol. 99, iss. 9, (2014), pp. 1492-1498)
sine al.
-
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial ; Kroeze, L.; ; Koorenhof-Scheele, T.N.; Massop, M.; Hoogen, P. van; Linders, E.H.P.; ; Tonnissen, E.; Heijden, A. van der; et al.2014, Article / Letter to editor (Annals of Hematology, vol. 93, iss. 8, (2014), pp. 1401-1412)
sine al.
-
Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to Myelodysplastic Syndrome or Leukemia from Severe Aplastic Anemia: A Report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Hussein, A.A.; Halkes, C.M.; Socie, G.; Tichelli, A.; Borne, P.A. von dem; Schaap, M.N.; Foa, R.; ; Dufour, C.; Bacigalupo, A.; et al.2014, Article / Letter to editor (Biology of Blood and Marrow Transplantation, vol. 20, iss. 9, (2014), pp. 1448-1450)
sine al.
-
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice ; Gratwohl, A.; ; Afanasyev, B.; Apperley, J.; Bacigalupo, A.; Dazzi, F.; Dreger, P.; Duarte, R.; ; et al.2014, Article / Letter to editor (Bone Marrow Transplantation, vol. 49, iss. 2, (2014), pp. 168-173)
sine al.
-
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide Morris, C.; Wreede, L. de; Scholten, M.; Brand, R.; ; Sureda, A.; Dickmeiss, E.; Trneny, M.; Apperley, J.; Chiusolo, P.; et al.2014, Article / Letter to editor (Transfusion, vol. 54, iss. 10, (2014), pp. 2514-2522)
sine al.
-
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation Lussana, F.; Rambaldi, A.; Finazzi, M.C.; ; Scholten, M.; Oldani, E.; Carobbio, A.; Iacobelli, S.; ; Nagler, A.; et al.2014, Article / Letter to editor (Haematologica, vol. 99, iss. 5, (2014), pp. 916-921)
sine al.
-
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation Alchalby, H.; Zabelina, T.; Stubig, T.; ; Bornhauser, M.; Bartolomeo, P. Di; Beelen, D.; Cahn, J.Y.; Dreger, P.; Schroyens, W.; et al.2014, Article / Letter to editor (Biology of Blood and Marrow Transplantation, vol. 20, iss. 2, (2014), pp. 279-281)
sine al.
-
-
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial) Willemze, R.; Suciu, S.; ; Halkes, C.J.; Meloni, G.; Meert, L.; Karrasch, M.; Rapion, J.; Vignetti, M.; Amadori, S.; et al.2014, Article / Letter to editor (Annals of Hematology, vol. 93, iss. 6, (2014), pp. 965-975)
sine al.
-
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial Willemze, R.; Suciu, S.; Meloni, G.; Labar, B.; Marie, J.P.; Halkes, C.J.; ; Mistrik, M.; Amadori, S.; Specchia, G.; et al.2014, Article / Letter to editor (Journal of Clinical Oncology, vol. 32, iss. 3, (2014), pp. 219-228)
sine al.
-
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party Onida, F.; Brand, R.; ; ; Borne, P.A. von dem; Maertens, J.; Beelen, D.W.; ; Alessandrino, E.P.; Volin, L.; et al.2014, Article / Letter to editor (Haematologica, vol. 99, iss. 10, (2014), pp. 1582-1590)
sine al.
-
Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study Wreede, L.C. de; Watson, M.; Os, M. van; Milligan, D.; Gelder, M. van; ; Dreger, P.; Dearden, C.E.; Homewood, J.; Dupuis, J.; et al.2014, Article / Letter to editor (American Journal of Hematology, vol. 89, iss. 2, (2014), pp. 174-180)
sine al.
-
Characterization of acute myeloid leukemia based on levels of global hydroxymethylation Kroeze, L.; ; Rooij, A. van; Koorenhof-Scheele, T.N.; Massop, M.; Carell, T.; ; Marie, J.P.; Halkes, C.J.; ; et al.2014, Article / Letter to editor (Blood, vol. 124, iss. 7, (2014), pp. 1110-1118)
sine al.
-
-
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients. ; ; ; ; Draaisma, A.L.; Esendam, B.; ; ; ; ; et al.2013, Article / Letter to editor (Cancer Immunology Immunotherapy, vol. 62, iss. 8, (2013), pp. 1381-1392)
sine al.
-
-
-
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation Basak, G.W.; Wreede, L.C. de; ; Wiktor-Jedrzejczak, W.; Halaburda, K.; Schmid, C.; ; Dazzi, F.; Borne, P.A. von dem; Petersen, E.; et al.2013, Article / Letter to editor (Bone Marrow Transplantation, vol. 48, iss. 6, (2013), pp. 837-842)
sine al.
-
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. ; Chateau, M. de; Krivan, G.; Rabitsch, W.; Szomor, A.; Pytlik, R.; Lissmats, A.; Johnsen, H.E.; ; Einsele, H.; et al.2013, Article / Letter to editor (Bone Marrow Transplantation, vol. 48, iss. 7, (2013), pp. 966-971)
sine al.
-
-
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome Deschler, B.; Ihorst, G.; Platzbecker, U.; Germing, U.; Marz, E.; de Figuerido, M.; Fritzsche, K.; Haas, P. de; Salih, H.R.; Giagounidis, A.; et al.2013, Article / Letter to editor (Haematologica, vol. 98, iss. 2, (2013), pp. 208-216)
sine al.
-
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes Bon, L. van; Broen, J.C.A.; ; Rueda, B.; Simeon, C.P.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; ; Hunzelmann, N.; Riemekasten, G.; et al.2013, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 31, iss. 2 Suppl 76, (2013), pp. 186)
sine al.
-
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17). Amadori, S.; Suciu, S.; Stasi, R.; Salih, H.R.; Selleslag, D.; ; Fabritiis, P. De; Venditti, A.; Ho, A.D.; Lubbert, M.; et al.2013, Article / Letter to editor (Journal of Clinical Oncology, vol. 31, iss. 35, (2013), pp. 4424-4430)
sine al.
-
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Auner, H.W.; Szydlo, R.; ; Iacobelli, S.; Gahrton, G.; Milpied, N.; Volin, L.; Janssen, J.; Nguyen Quoc, S.; ; et al.2013, Article / Letter to editor (Bone Marrow Transplantation, vol. 48, iss. 11, (2013), pp. 1395-1400)
sine al.
-
Induction of myelodysplasia by myeloid-derived suppressor cells ; Eksioglu, E.A.; Zhou, J; Zhang, L.; Djeu, J.; Fortenbery, N.; Epling-Burnette, P.; Bijnen, S. Van; ; Cannon, J.; et al.2013, Article / Letter to editor (Journal of Clinical Investigation, vol. 123, iss. 11, (2013), pp. 4595-4611)
sine al.
-
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings Kroger, N.; Zabelina, T.; Wreede, L. de; Berger, J.; Alchalby, H.; ; Milpied, N.; Volin, L.; Mohty, M.; Leblond, V.; et al.2013, Article / Letter to editor (Leukemia, vol. 27, iss. 3, (2013), pp. 604-609)
sine al.
-
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation ; ; ; Greupink-Draaisma, A.L.; Adisty, N.; Wouters, Y.; Kester, M.; ; ; ; et al.2013, Article / Letter to editor (Biology of Blood and Marrow Transplantation, vol. 19, iss. 2, (2013), pp. 274-282)
sine al.
-
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study Gahrton, G.; Iacobelli, S.; Bjorkstrand, B.; Hegenbart, U.; Gruber, A.; Greinix, H.; Volin, L.; Narni, F.; Carella, A.M.; Beksac, M.; et al.2013, Article / Letter to editor (Blood, vol. 121, iss. 25, (2013), pp. 5055-5063)
sine al.
-
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT Martino, R.; Wreede, L. de; Fiocco, M.; ; Borne, P.A. von dem; Hamladji, R.M.; Volin, L.; Bornhauser, M.; Robin, M.; Rocha, V.; et al.2013, Article / Letter to editor (Bone Marrow Transplantation, vol. 48, iss. 6, (2013), pp. 761-770)
sine al.
-
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group Loosdrecht, A.A. van de; Ireland, R.; Kern, W.; Della Porta, M.G.; Alhan, C.; Balleisen, J.S.; Bettelheim, P.; Bowen, D.T.; Burbury, K.; Eidenschink, L.; et al.2013, Article / Letter to editor (Leukemia & Lymphoma, vol. 54, iss. 3, (2013), pp. 472-475)
sine al.
-
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Malcovati, L.; Hellstrom-Lindberg, E.; Bowen, D.; Ades, L.; Cermak, J.; Canizo, C. Del; Porta, M.G. Della; Fenaux, P.; Gattermann, N.; Germing, U.; et al.2013, Article / Letter to editor (Blood, vol. 122, iss. 17, (2013), pp. 2943-2964)
sine al.
-
-
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data Brand, R.; Putter, H.; ; Niederwieser, D.; Martino, R.; Mufti, G.; Onida, F.; Symeonidis, A.; Schmid, C.; Garderet, L.; et al.2013, Article / Letter to editor (PLoS One, vol. 8, iss. 10, (2013), article e74368)
sine al.
-
-
-
Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Garderet, L.; Iacobelli, S.; Moreau, P.; Dib, M.; Lafon, I.; Niederwieser, D.; Masszi, T.; Fontan, J.; ; Gratwohl, A.; et al.2012, Article / Letter to editor (Journal of Clinical Oncology, vol. 30, iss. 20, (2012), pp. 2475-2482)
sine al.
-
-
-
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis Teruel, M.; Simeon, C.P.; Broen, J.C.A.; ; Carreira, P.; Camps, M.T.; Garcia-Portales, R.; Delgado-Frias, E.; Gallego, M.; Espinosa, G.; et al.2012, Article / Letter to editor (Arthritis Research & Therapy, vol. 14, iss. 3, (2012), pp. R154)
sine al.
-
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium. Wiktor-Jedrzejczak, W.; Dearden, C.; Wreede, L. de; ; Brinch, L.; Leblond, V.; Brune, M.; Volin, L.; Kazmi, M.; Nagler, A.; et al.2012, Article / Letter to editor (Leukemia, vol. 26, iss. 5, (2012), pp. 972-976)
sine al.
-
EORTC Leukemia Group Achievements Willemze, R.; Suciu, S.; Marie, J.P.; Karrasch, M.; ; Amadori, S.; ; Labar, B.; Baron, F.; Selleslag, D.; et al.2012, Article / Letter to editor (European Journal of Cancer, vol. 10, (2012), pp. 94-98)
sine al.
-
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. Hengeveld, M.; Suciu, S.; Karrasch, M.; Specchia, G.; Marie, J.P.; ; Petti, M.C.; Rotoli, B.; Amadori, S.; Fioritoni, G.; et al.2012, Article / Letter to editor (Annals of Hematology, vol. 91, iss. 6, (2012), pp. 825-835)
sine al.
-
The EBMT activity survey: 1990-2010. Passweg, J.R.; Baldomero, H.; Gratwohl, A.; Bregni, M.; Cesaro, S.; Dreger, P.; ; Farge-Bancel, D.; Gaspar, B.; Marsh, J.; et al.2012, Article / Letter to editor (Bone Marrow Transplantation, vol. 47, iss. 7, (2012), pp. 906-923)
sine al.
-
Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group. Baron, F.; Suciu, S.; Amadori, S.; ; Zwierzina, H.; Denzlinger, C.; Delforge, M.; Thyss, A.; Selleslag, D.; Indrak, K.; et al.2012, Article / Letter to editor (Haematologica, vol. 97, iss. 4, (2012), pp. 529-533)
sine al.
-
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation. Cwynarski, K.; ; Wreede, L. de; Stilgenbauer, S.; ; Metzner, B.; Koza, V.; Mohty, M.; Remes, K.; Russell, N.; et al.2012, Article / Letter to editor (Journal of Clinical Oncology, vol. 30, iss. 18, (2012), pp. 2211-2217)
sine al.
-
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Westers, T.M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J.S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J.A.; Porta, M.G. Della; et al.2012, Article / Letter to editor (Leukemia, vol. 26, iss. 7, (2012), pp. 1730-1741)
sine al.
-
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. ; ; Hertenstein, B.; Henseler, A.; Garderet, L.; Passweg, J.; Mohty, M.; Sureda, A.; Niederwieser, D.; Gratwohl, A.; et al.2012, Article / Letter to editor (Bone Marrow Transplantation, vol. 47, iss. 11, (2012), pp. 1459-1464)
sine al.
Now showing items 51-100 of 356
Upload Full Text